Donna D. Eason, Ph.D. - Publications

Affiliations: 
2000 University of South Florida, Tampa, FL, United States 
Area:
Molecular Biology, Immunology, Oncology

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Shah RN, Rodriguez-Nunez I, Eason DD, Haire RN, Bertrand JY, Wittamer V, Traver D, Nordone SK, Litman GW, Yoder JA. Development and characterization of anti-nitr9 antibodies. Advances in Hematology. 2012: 596925. PMID 23049557 DOI: 10.1155/2012/596925  0.423
2008 Cannon JP, Haire RN, Magis AT, Eason DD, Winfrey KN, Hernandez Prada JA, Bailey KM, Jakoncic J, Litman GW, Ostrov DA. A bony fish immunological receptor of the NITR multigene family mediates allogeneic recognition. Immunity. 29: 228-37. PMID 18674935 DOI: 10.1016/J.Immuni.2008.05.018  0.414
2007 Litman GW, Cannon JP, Dishaw LJ, Haire RN, Eason DD, Yoder JA, Prada JH, Ostrov DA. Immunoglobulin variable regions in molecules exhibiting characteristics of innate and adaptive immune receptors. Immunologic Research. 38: 294-304. PMID 17917037 DOI: 10.1007/S12026-007-0014-2  0.346
2006 Cannon JP, Haire RN, Mueller MG, Litman RT, Eason DD, Tinnemore D, Amemiya CT, Ota T, Litman GW. Ancient divergence of a complex family of immune-type receptor genes. Immunogenetics. 58: 362-73. PMID 16738934 DOI: 10.1007/S00251-006-0112-7  0.408
2004 Eason DD, Cannon JP, Haire RN, Rast JP, Ostrov DA, Litman GW. Mechanisms of antigen receptor evolution. Seminars in Immunology. 16: 215-26. PMID 15522620 DOI: 10.1016/J.Smim.2004.08.001  0.422
2004 Eason DD, Litman RT, Luer CA, Kerr W, Litman GW. Expression of individual immunoglobulin genes occurs in an unusual system consisting of multiple independent loci. European Journal of Immunology. 34: 2551-8. PMID 15307187 DOI: 10.1002/Eji.200425224  0.419
2003 Eason DD, LeBron C, Coppola D, Moscinski LC, Livingston S, Sutton ET, Blanck G. Development of CD30+ lymphoproliferative disease in mice lacking interferon regulatory factor-1. Oncogene. 22: 6166-76. PMID 13679855 DOI: 10.1038/Sj.Onc.1206563  0.518
2002 Eason DD, Litman GW. Haplotype exclusion: the unique case presented by multiple immunoglobulin gene loci in cartilaginous fish. Seminars in Immunology. 14: 145-52; discussion 2. PMID 12160642 DOI: 10.1016/S1044-5323(02)00038-6  0.385
2002 Yoder JA, Hawke NA, Eason DD, Mueller MG, Davids BJ, Gillin FD, Litman GW. BIVM, a novel gene widely distributed among deuterostomes, shares a core sequence with an unusual gene in Giardia lamblia. Genomics. 79: 750-5. PMID 12036287 DOI: 10.1006/Geno.2002.6768  0.337
2001 Eason DD, Coppola D, Livingston S, Shepherd AT, Blanck G. Loss of MHC class II inducibility in hyperplastic tissue in Rb-defective mice. Cancer Letters. 171: 209-14. PMID 11520605 DOI: 10.1016/S0304-3835(01)00603-6  0.67
2001 Goodwin BL, Xi H, Tejiram R, Eason DD, Ghosh N, Wright KL, Nagarajan U, Boss JM, Blanck G. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 12: 327-35. PMID 11432807  0.685
2001 Eason DD, Blanck G. High level class II trans-activator induction does not occur with transient activation of the IFN-gamma signaling pathway. Journal of Immunology (Baltimore, Md. : 1950). 166: 1041-8. PMID 11145683 DOI: 10.4049/Jimmunol.166.2.1041  0.683
1999 Xi H, Eason DD, Ghosh D, Dovhey S, Wright KL, Blanck G. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2. Oncogene. 18: 5889-903. PMID 10557076 DOI: 10.1038/Sj.Onc.1202969  0.677
1999 Zhang H, Shepherd AT, Eason DD, Wei S, Diaz JI, Djeu JY, Wu GD, Blanck G. Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 10: 457-65. PMID 10437913  0.734
1999 Eason DD, Shepherd AT, Blanck G. Interferon regulatory factor 1 tryptophan 11 to arginine point mutation abolishes DNA binding. Biochimica Et Biophysica Acta. 1446: 140-4. PMID 10395927 DOI: 10.1016/S0167-4781(99)00078-0  0.572
Show low-probability matches.